Navigation Links
BioCryst to Present at UBS 2008 Global Life Sciences Conference
Date:9/16/2008

BIRMINGHAM, Ala., Sept. 16 /PRNewswire-FirstCall/ --BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Jon P. Stonehouse, Chief Executive Officer and President of BioCryst, will present a corporate update at the UBS 2008 Global Life Sciences Conference in New York on Tuesday, September 23, 2008 at 2:00 p.m. Eastern Time.

A link to a live audio Web cast of the presentation may be accessed on the BioCryst Web site http://www.biocryst.com. The presentation will be archived for 30 days.

About BioCryst

BioCryst is an integrated biopharmaceutical company utilizing crystallography and structure-based drug design to develop a deep pipeline of novel therapeutics targeting major illnesses. BioCryst is currently advancing investigational new drugs discovered in-house in late-stage clinical trials for influenza and lymphoma. In addition, the Company has a pre-clinical portfolio of novel compounds, directed against infectious, cardiovascular, and autoimmune disease targets, to create long-term sustainable value. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross Corporation and Mundipharma International Holdings Ltd. validate its scientific foundation and the utility of its product candidates. For more information, please visit the Company's website at http://www.biocryst.com.

Forward-looking statements

This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
2. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
3. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
4. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
6. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
7. BioCryst to Present at UBS 2007 Global Life Sciences Conference
8. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
9. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
10. Symmetry Medical to Present at UBS Global Life Sciences Conference
11. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 The new ... Spain , available today on PharmaBoardroom.com for ... Eurozone crisis that rocked the Spanish economy in 2009, and ... pharma community has remained pragmatic in times of trouble. ... still the fifth biggest European market, and the general conditions ...
(Date:9/18/2014)... A novel robotic system that can operate ... being tested as part of a biomedical research partnership ... the aim of determining if the robot, in conjunction ... faster, more accurate, less costly, and less discomforting for ... to deliver prostate cancer therapies with greater precision. , ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global and Chinese Stem Cell Industry Report, 2014-2017" ... are undifferentiated biological cells that can differentiate into specialized ... stem cells. Stem cell therapy can be applied to ... system disease), nervous system diseases, damage or lesion of ...
(Date:9/18/2014)... 2014  U.S. biotech company Kultevat has ... for technology developed by the Donald Danforth Plant ... including for applications in production of natural rubber in ... was developed under the direction of Roger Beachy ... president of the Danforth Plant Science Center, and is ...
Breaking Biology Technology:PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Kultevat obtains license of gene switch technology 2
... Israel, Jan. 31, 2012   InspireMD, Inc. (OTC BB: ... company focusing on the development and commercialization of ... patients with Acute Myocardial Infarctions, today announced the ... of Directors as an independent director.  Dr. Barry ...
... of the wonders of the science world, with the potential ... next generation of aircraft. The new finding at the University ... graphene can also be used for distilling alcohol. In ... by Professor Sir Andre Geim shows that graphene-based membranes are ...
... on previous research in which microbubbles were used to improve ... which can be processed to create a useful biofuel. Biofuels, ... fossil fuels and algae, in particular, has the potential to ... has been no cost-effective method of harvesting and removing the ...
Cached Biology Technology:InspireMD Appoints Dr. James Barry to Its Board of Directors 2InspireMD Appoints Dr. James Barry to Its Board of Directors 3InspireMD Appoints Dr. James Barry to Its Board of Directors 4Supermaterial goes superpermeable 2Microbubbles provide new boost for biofuel production 2
(Date:9/18/2014)... Worcester, Mass. A novel robotic system that can ... currently being tested as part of a biomedical research ... with the aim of determining if the robot, in ... biopsies faster, more accurate, less costly, and less discomforting ... potential to deliver prostate cancer therapies with greater precision. ...
(Date:9/18/2014)... that prompts millions of Americans to undertake jaunts into the ... a little longer within a century, according to new research. ... areas of the United States as summer temperatures linger later ... Global Ecology and Biogeography . For instance, the paper ... tree of New Hampshire could change color one to ...
(Date:9/18/2014)... Sept. 18, 2014 -- Arizona turned its newborn screening program ... few short months, earning it the first-ever Newborn Screening Quality ... of Dimes presented Will Humble, M.P.H., Arizona,s Department of Health ... today. Mr. Humble established a policy of full transparency for ... newborn blood samples to the lab for analysis, and set ...
Breaking Biology News(10 mins):Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 3
... genome of a marine bacterium living 2,500 meters below ... adapts in extreme thermal and chemical gradients, according to ... PLoS Genetics , an open-access publication published by the ... the bacterium Nautilia profundicola , a microbe that ...
... in Arizona,s Santa Catalina Mountains as summer temperatures rise, ... in Tucson. The flowering ranges of 93 plant ... where the same species flowered the previous ten years. ... region increased about 1.8 degree Fahrenheit (1 degree C.). ...
... wondered how melanoma cells travel from primary tumors on the ... they become more aggressive, resistant to therapy, and deadly. Now, ... short strand of RNA called microRNA (miRNA) that is over-expressed in ... ...
Cached Biology News:Genetic adaptations key to microbe's survival in challenging environment 2Plants take a hike as temperatures rise 2Plants take a hike as temperatures rise 3NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis 2NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis 3
Request Info...
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: